Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research1

FiltersClear all

Status

Active, not recruiting1

Study type

Interventional1

Phase

Phase 31
Phase 24
Not reported1

Investigator

Jean W. Pape1

Department

Medicine1

Condition

Breast Neoplasms17
Obesity15
COVID-1912
Overweight12
Crohn Disease11

Show all 50Show fewer

Intervention type

Dietary supplement1
Drug1

Sponsor type

NIH1

Start date

to

Phase 3×Tuberculosis×Clear all

Showing 1–1 of 1 studySort:

Active, not recruitingInterventional · Phase 3NCT03568383 ↗
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)
Jean W. Pape

PI

Intervention: Drug: Delamanid (DLM) · Drug: Isoniazid (INH) · Dietary supplement: Pyridoxine (vitamin B6)
Dates: Jun 2019 – Nov 2026 (est.)
Sponsor: National Institute of Allergy & Infectious Diseases

Tuberculosis, MDR